Expression profiles of vault components MVP, TEP1 and vPARP and their correlation to other multidrug resistance proteins in ovarian cancer

Author：                    

Publisher： Spandidos Publications

ISSN： 1019-6439

Source： International Journal of Oncology, Vol.43, Iss.2, 2013-01, pp. : 513-520

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Differential Expression of Axl and Correlation with Invasion and Multidrug Resistance in Cancer Cells

By Zhao Yongfu   Sun Xiance   Jiang Lili   Yang Fengjuan   Zhang Zhaohai   Jia Li  

Cancer Investigation, Vol. 30, Iss. 4, 2012-04 ,pp. : 287-294

Informa Healthcare

Access to resources Recommend Favorite

Chemosensitivity of prostate cancer cell lines and expression of multidrug resistance-related proteins

By van Brussel J.P.   van Steenbrugge G.J.   Romijn J.C.   Schroder F.H.   Mickisch G.H.J.  

European Journal of Cancer, Vol. 35, Iss. 4, 1999-04 ,pp. : 664-671

Elsevier

Access to resources Recommend Favorite

PARP Inhibitors in Ovarian Cancer

By  

Recent Patents on Anti-Cancer Drug Discovery, Vol. 13, Iss. 4, 2018-11 ,pp. : 392-410

Bentham Science Publishers

Access to resources Recommend Favorite

Multidrug Resistance Gene-1 Is a Useful Predictor of Paclitaxel-Based Chemotherapy for Patients with Ovarian Cancer

By Kamazawa S.   Kigawa J.   Kanamori Y.   Itamochi H.   Sato S.   Iba T.   Terakawa N.  

Gynecologic Oncology, Vol. 86, Iss. 2, 2002-08 ,pp. : 171-176

Academic Press

Access to resources Recommend Favorite

Expression of the multidrug resistance gene in human prostate cancer

By Bhangal G.   Halford S.   Wang J.   Roylance R.   Shah R.   Waxman J.  

Urologic Oncology: Seminars and Original Investigations, Vol. 5, Iss. 3, 2000-04 ,pp. : 118-121

Elsevier

Access to resources Recommend Favorite